Skip to content
March 7, 2026
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • tiktok
MILLENNIUM NEWS 24/7

MILLENNIUM NEWS 24/7

Bridging The Community’s World Wide

  • Home
  • IP TV LIVE
  • U.S.News
  • LOCAL ELECTION
  • State News
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • California
    • Colorado
    • Connecticut
    • Delaware
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Indiana
    • Iowa
    • Kansas
    • Kentucky
    • Louisiana
    • Maryland
    • Massachusetts
    • Michigan
    • Maine
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nebraska
    • Nevada
    • New Hampshire
    • New Jersey
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Virginia
    • Washington
    • West Virginia
    • U.S. Virgin Islands
  • Politics
  • World News
  • Sports
  • Entertainment
  • Weather
  • Business
  • Health News
  • ADVERTISEMENT
  • About Us
  • Contact us
Live TV

CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors

CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.

The drug store chain said it will remove a small number of oral decongestants that contain phenylephrine as the only active ingredient. CVS also said it will still sell “many other oral cough and cold products to meet consumer needs.”

A company spokeswoman declined to elaborate on how many products will be removed when contacted by The Associated Press Friday morning.

CVS Health runs more than 9,000 stores in the United States. Representatives of its national rival, Walgreens, has not pulled any products.

A Walgreens spokeswoman said the company is monitoring the situation and partnering with its clinical integrity office and suppliers “on appropriate next steps.”

U.S. Food and Drug Administration advisers voted unanimously last month against the effectiveness of phenylephrine, which is found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.

The FDA had asked its outside advisers to examine the long-questioned drug ingredient. Studies conducted in the past few years by the drugmakers Merck and Johnson & Johnson have shown no difference between phenylephrine medications and placebos for relieving congestion.

The FDA, which has not acted on the recommendation of its advisers, said the drug appears more effective when applied directly to the nose, in sprays or drops. Those products are not under review.

Phenylephrine had become the main drug in over-the-counter decongestants when medicines with an older ingredient — pseudoephedrine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephedrine can be illegally processed into methamphetamine.

Those original versions of Sudafed and other medicines remain available without a prescription.

The CVS Health announcement comes shortly before another cold-and-flu season starts in the United States as winter sets in. Last year, an unusually fast start to the season led to shortages of Children’s Tylenol and other medications customers can purchase over-the-counter, or without a prescription.

 

 

About Author

dreamboy

See author's posts

Post navigation

Previous Stock market today: Asian shares slip further as higher US 10-year Treasury yield pressures Wall St
Next There isn’t much Cher hasn’t done in her career. A Christmas album is new territory, though

Related Stories

Panic at Pakistan Fuel Stations Amid Anticipation of Price Hike Due to Iran War

Panic at Pakistan Fuel Stations Amid Anticipation of Price Hike Due to Iran War

US Issues Limited Licence for Venezuelan Gold after High-Level Visit

US Issues Limited Licence for Venezuelan Gold after High-Level Visit

US Customs Agency Delays Reimbursement of Tariff Costs Amid Process Development

US Customs Agency Delays Reimbursement of Tariff Costs Amid Process Development

Entertainment

Nomadic Art Haven Opens in Qatar’s Desert 1

Nomadic Art Haven Opens in Qatar’s Desert

BBC Initiates Swift Probe Over Unedited Racial Slur in BAFTA Broadcast 2

BBC Initiates Swift Probe Over Unedited Racial Slur in BAFTA Broadcast

UK Comic Russell Brand Pleads Not Guilty to New Rape and Sexual Assault Charges 3

UK Comic Russell Brand Pleads Not Guilty to New Rape and Sexual Assault Charges

BBC Faces Backlash for Removing ‘Free Palestine’ Tribute from BAFTA Coverage 4

BBC Faces Backlash for Removing ‘Free Palestine’ Tribute from BAFTA Coverage

BBC Faces Backlash for Removing ‘Free Palestine’ Tribute from BAFTA Coverage 5

BBC Faces Backlash for Removing ‘Free Palestine’ Tribute from BAFTA Coverage

Tourette Syndrome Campaigner Involuntarily Shouts Racial Slur at BAFTA Film Awards 6

Tourette Syndrome Campaigner Involuntarily Shouts Racial Slur at BAFTA Film Awards

Tourette Syndrome Campaigner Involuntarily Shouts Racial Slur at BAFTA Ceremony 7

Tourette Syndrome Campaigner Involuntarily Shouts Racial Slur at BAFTA Ceremony

Top News

Iran War Live: Tehran Vows Never to Surrender as Conflict Enters Eighth Day

Iran War Live: Tehran Vows Never to Surrender as Conflict Enters Eighth Day

Iran’s President Masoud Pezeshkian Issues Apology for Attacks on Neighboring Countries

Iran’s President Masoud Pezeshkian Issues Apology for Attacks on Neighboring Countries

US Downplays Reports of Russian Intelligence Support to Iran Amid Regional Tensions

US Downplays Reports of Russian Intelligence Support to Iran Amid Regional Tensions

Iran Declares Conditional Halt to Strikes on Neighboring Countries Amid Ongoing Conflict

Iran Declares Conditional Halt to Strikes on Neighboring Countries Amid Ongoing Conflict

  • Home
  • About Us
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • tiktok
Editor: Nur M Tofader, Office: 250 Park Avenue, 7th Floor, New York, NY 10177 & Tell: 718 893 0002 (Office), 7188441300, +1212 401 6266, e-mail: Info@millenniuamtv24.com, e-mail: Info@millenniuamnews24.com, Copyright © Millennium News 24/7 | DarkNews by AF themes.